RAF1 and cardiac hypertrophy: Inhibition of the ERK pathway via dominant negative Raf or cardiac specific deletion of c-raf-1 attenuated pathological cardiac hypertrophy (Yamaguchi et al., 2004; Goldsmith and Dhanasekaran, 2007).